TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare Conference
July 09 2021 - 7:30AM
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael
S. Weiss, the Company’s Chairman and Chief Executive Officer, will
participate in a fireside chat during the Ladenburg Thalmann 2021
Healthcare Conference being held virtually. The fireside chat is
scheduled to take place on Wednesday, July 14, 2021 at 12:30 PM ET.
A live webcast of each presentation will be available on the
Events page, located within the Investors & Media section, of
the Company’s website at https://ir.tgtherapeutics.com/events.
Following each event, an archive file will be available for thirty
days.
ABOUT TG THERAPEUTICS, INC.TG
Therapeutics is a fully-integrated, commercial stage
biopharmaceutical company focused on the acquisition, development
and commercialization of novel treatments for B-cell malignancies
and autoimmune diseases. In addition to an active research pipeline
including five investigational medicines across these therapeutic
areas, TG has received accelerated approval from
the U.S. FDA for UKONIQ™ (umbralisib), for the
treatment of adult patients with relapsed/refractory marginal zone
lymphoma who have received at least one prior anti-CD20-based
regimen and relapsed/refractory follicular lymphoma who have
received at least three prior lines of systemic therapies.
Currently, the Company has three programs in Phase 3 development
for the treatment of patients with relapsing forms of multiple
sclerosis (RMS) and patients with chronic lymphocytic leukemia
(CLL) and several investigational medicines in Phase 1 clinical
development. For more information,
visit www.tgtherapeutics.com, and follow us on
Twitter @TGTherapeutics and Linkedin.
UKONIQ™ is a trademark of TG Therapeutics, Inc.
CONTACT:
Investor Relations
Email: ir@tgtxinc.comTelephone: 1.877.575.TGTX (8489), Option 4
Media Relations:
Email: media@tgtxinc.comTelephone: 1.877.575.TGTX (8489), Option
6
TG Therapeutics (NASDAQ:TGTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
TG Therapeutics (NASDAQ:TGTX)
Historical Stock Chart
From Apr 2023 to Apr 2024